Ropinirol (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ropinirol" in Spanish language version.

refsWebsite

Global rank Spanish rank

2^nd place

2^nd place

4^th place

4^th place

1genengnews.com

low place

low place

57^th place

3^rd place

1web.archive.org

1^st place

1^st place

low place

low place

610^th place

332^nd place

6^th place

5^th place

archive.org

Eden, R. J. et al. (1991). «Preclinical Pharmacology of Ropinirole (SK&F 101468-A) a Novel Dopamine D 2 Agonist». Pharmacology Biochemistry & Behavior 38: 147-154. doi:10.1016/0091-3057(91)90603-Y.

doi.org

dx.doi.org

Tompson, Debra J. et al. (2007). «Steady-State Pharmacokinetic Properties of a 24-Hour Prolonged-Release Formulation of Ropinirole: Results of Two Randomized Studies in Patients with Parkinson’s Disease». Clinical Pharmacokinetics 29: 2654. doi:10.1016/j.clinthera.2007.12.010.
Garcia-Borreguero D, Grunstein R, Sridhar G, et al. (noviembre de 2007). «A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome». Sleep Med. 8 (7-8): 742-52. PMID 17512789. doi:10.1016/j.sleep.2006.09.009.
Eden, R. J. et al. (1991). «Preclinical Pharmacology of Ropinirole (SK&F 101468-A) a Novel Dopamine D 2 Agonist». Pharmacology Biochemistry & Behavior 38: 147-154. doi:10.1016/0091-3057(91)90603-Y.

elsevier.com

linkinghub.elsevier.com

Garcia-Borreguero D, Grunstein R, Sridhar G, et al. (noviembre de 2007). «A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome». Sleep Med. 8 (7-8): 742-52. PMID 17512789. doi:10.1016/j.sleep.2006.09.009.

genengnews.com

Lipp, Elizabeth (8 de enero de 2008). «Novel Approaches to Lead Optimization». Genetic Engineering & Biotechnology News. Drug Discovery (Mary Ann Liebert) 28 (14): 20. ISSN 1935-472X. Consultado el 28 de septiembre de 2008.

issn.org

portal.issn.org

Lipp, Elizabeth (8 de enero de 2008). «Novel Approaches to Lead Optimization». Genetic Engineering & Biotechnology News. Drug Discovery (Mary Ann Liebert) 28 (14): 20. ISSN 1935-472X. Consultado el 28 de septiembre de 2008.

nih.gov

ncbi.nlm.nih.gov

Garcia-Borreguero D, Grunstein R, Sridhar G, et al. (noviembre de 2007). «A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome». Sleep Med. 8 (7-8): 742-52. PMID 17512789. doi:10.1016/j.sleep.2006.09.009.
Bostwick JM, Hecksel KA, Stevens SR, Bower JH, Ahlskog JE. Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease. Mayo Clinic Proceedings. 2009 Apr;84(4):310-6. PMID 19339647

tevausa.com

«New pharmaceutical products: Ceftriaxon-Rocephin, Granisetron-Kytril, Ipratropium-Albuterol». Archivado desde el original el 8 de noviembre de 2011. Consultado el 16 de mayo de 2010.

web.archive.org

«New pharmaceutical products: Ceftriaxon-Rocephin, Granisetron-Kytril, Ipratropium-Albuterol». Archivado desde el original el 8 de noviembre de 2011. Consultado el 16 de mayo de 2010.